Riverview Trust »

Cerevel Therapeutics Hldng I shares owned by Riverview Trust

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Riverview Trust from 13F filings

Historical chart of Riverview Trust investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Riverview Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Riverview Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $16k 385 42.27

More positions owned by Riverview Trust

Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard REIT ETF (VNQ)
Vanguard Large-Cap ETF (VV)
Facebook Inc cl a (META)
Amazon (AMZN)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Alphabet Inc Class C cs (GOOG)
iShares Lehman Aggregate Bond (AGG)
Intel Corporation (INTC)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Riverview Trust

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I